Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of CCND1 alterations during the progression of cutaneous malignant melanoma.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Dec 2012

Vízkeleti Laura, Ecsedi Szilvia, Rákosy Zsuzsa, Orosz Adrienn, Lázár Viktória, Emri Gabriella, Koroknai Viktória, Kiss Tímea, Ádány Róza, Balázs Margit

Abstract excerpt

It is well demonstrated that CCND1 amplification is a frequent event in the acral subtype of cutaneous malignant melanoma; however, its role in the other subtypes of the disease is still controversial. The objectives of this study were to evaluate genetic and expression alterations of CCND1 with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Comparative Genomic Hybridization
Share to Cyclin D1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, ras

Share to Immunoenzyme Techniques

Share to In Situ Hybridization, Fluorescence

Share to Lymphatic Metastasis

Share to Skin Neoplasms

Share to Survival Rate

Source

Identifiers

PMID: 23001925
DOI: 10.1007/s13277-012-0480-6

Genes

CCND1
BRAF
NRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23001925-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of CCND1 alterations during the progression of cutaneous malignant melanoma.PMID 23001925Read ↗

An update on the implications of cyclin D1 in melanomasSemantic proximity Read ↗

[Biological role and prognostic significance of genetic alterations in human malignant melanomas].Semantic proximity Read ↗

Molecular characterization and patient outcome of melanoma nodal metastases and an unknown primary site.Semantic proximity Read ↗

Discoidin domain receptors: A promising target in melanomaSemantic proximity Read ↗

Clinicopathologic and molecular characterization of melanomas mutated for CTNNB1 and MAPK.Semantic proximity Read ↗

[Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].Semantic proximity Read ↗

Frequency of CDK2 , CCNE1 Copy Number Variation in Acral Melanoma and Implications for CDK Inhibitor in Targeted TherapySemantic proximity Read ↗

Constitutive Activation of the Mitogen-Activated Protein Kinase Signaling Pathway in Acral MelanomasSemantic proximity Read ↗

Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma.Semantic proximity Read ↗

Clinical correlates of NRAS and BRAF mutations in primary human melanoma.Semantic proximity Read ↗

Loss of CDKN 2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK 4/6 inhibitor PD 0332991 in melanoma cell linesSemantic proximity Read ↗

Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.